Share prices for Amityville-based drugmaker Hi-Tech Pharmacal have been surging through the trading day on news of a $1.9 billion buyout within the pharmaceutical industry. Hi-Tech's stock is up over ...
Co announces the FDA granted tentative approval to the co's Abbreviated New Drug Application for Calcipotriene topical solution, 0.005%. Hi-Tech's Calcipotriene topical solution is the generic ...
Co announces it entered into a settlement and release agreement regarding the patent infringement suit brought by MedPointe Pharmaceuticals related to Hi-Tech's generic version of Tussi-12 DS, covered ...
ATLANTA (CN) — A federal appeals court heard arguments Tuesday from a pharmaceutical company that claims it shouldn’t have to pay the Federal Trade Commission a $40 million judgment for violating an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback